Comprehensive Stock Comparison
Compare Perella Weinberg Partners (PWP) vs Nomura Holdings, Inc. (NMR) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | PWP | 35.4% revenue growth vs NMR's 13.4% |
| Value | NMR | Lower P/E (11.3x vs 14.3x) |
| Quality / Margins | NMR | 7.6% net margin vs PWP's -7.4% |
| Stability / Safety | NMR | Beta 1.19 vs PWP's 1.62 |
| Dividends | NMR | 2.6% yield, 2-year raise streak, vs PWP's 2.1% |
| Momentum (1Y) | NMR | +45.9% vs PWP's -18.7% |
| Efficiency (ROA) | PWP | 7.2% ROA vs NMR's 0.6%, ROIC -13.7% vs 1.0% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Perella Weinberg Partners is an independent investment bank that provides strategic advisory services for mergers, acquisitions, and capital markets transactions. It generates revenue primarily from advisory fees — roughly 80% from M&A and restructuring work — with the remainder from capital markets and other financial advisory services. The firm's key advantage is its boutique partnership model, which attracts top talent and fosters deep client relationships without the conflicts of interest common at larger universal banks.
Nomura Holdings is a Japanese financial services conglomerate that operates as a full-service investment bank and securities firm. It generates revenue primarily through its Wholesale segment — investment banking, trading, and securities underwriting — which contributes roughly 60-70% of total revenue, supplemented by Retail brokerage and Investment Management services. The company's key advantage is its dominant position in Japan's domestic capital markets and its extensive Asian franchise, which provides deep client relationships and local market expertise.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
NMR leads in 4 of 6 categories (Financial Metrics, Total Returns). PWP leads in 1 (Profitability & Efficiency). 1 tied.
Financial Metrics (TTM)
NMR is the larger business by revenue, generating $4.51T annually — 5132.6x PWP's $878M. NMR is the more profitable business, keeping 7.6% of every revenue dollar as net income compared to PWP's -7.4%.
| Metric | PWPPerella Weinberg … | NMRNomura Holdings, … |
|---|---|---|
| RevenueTrailing 12 months | $878M | $4.51T |
| EBITDAEarnings before interest/tax | $71M | $533.0B |
| Net IncomeAfter-tax profit | $47M | $370.1B |
| Free Cash FlowCash after capex | $74M | $0 |
| Gross MarginGross profit ÷ Revenue | +40.1% | +36.9% |
| Operating MarginEBIT ÷ Revenue | -8.9% | +10.5% |
| Net MarginNet income ÷ Revenue | -7.4% | +7.6% |
| FCF MarginFCF ÷ Revenue | +23.6% | -19.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -66.2% | -5.5% |
Valuation Metrics
| Metric | PWPPerella Weinberg … | NMRNomura Holdings, … |
|---|---|---|
| Market CapShares × price | $434M | $26.6B |
| Enterprise ValueMkt cap + debt − cash | $289M | $192.1B |
| Trailing P/EPrice ÷ TTM EPS | -15.17x | 12.66x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.35x | 11.35x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.16x |
| EV / EBITDAEnterprise value multiple | — | 56.19x |
| Price / SalesMarket cap ÷ Revenue | 0.49x | 0.92x |
| Price / BookPrice ÷ Book value/share | 4.28x | 1.20x |
| Price / FCFMarket cap ÷ FCF | 2.10x | — |
Profitability & Efficiency
PWP delivers a 23.4% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $10 for NMR. PWP carries lower financial leverage with a 0.82x debt-to-equity ratio, signaling a more conservative balance sheet compared to NMR's 8.75x. On the Piotroski fundamental quality scale (0–9), NMR scores 7/9 vs PWP's 6/9, reflecting strong financial health.
| Metric | PWPPerella Weinberg … | NMRNomura Holdings, … |
|---|---|---|
| ROE (TTM)Return on equity | +23.4% | +10.3% |
| ROA (TTM)Return on assets | +7.2% | +0.6% |
| ROICReturn on invested capital | -13.7% | +1.0% |
| ROCEReturn on capital employed | -16.7% | +2.1% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.82x | 8.75x |
| Net DebtTotal debt minus cash | -$145M | $25.83T |
| Cash & Equiv.Liquid assets | $333M | $5.51T |
| Total DebtShort + long-term debt | $187M | $31.35T |
| Interest CoverageEBIT ÷ Interest expense | — | 0.20x |
Total Returns (with DRIP)
A $10,000 investment in PWP five years ago would be worth $18,682 today (with dividends reinvested), compared to $16,957 for NMR. Over the past 12 months, NMR leads with a +45.9% total return vs PWP's -18.7%. The 3-year compound annual growth rate (CAGR) favors NMR at 33.4% vs PWP's 24.2% — a key indicator of consistent wealth creation.
| Metric | PWPPerella Weinberg … | NMRNomura Holdings, … |
|---|---|---|
| YTD ReturnYear-to-date | +5.9% | +6.5% |
| 1-Year ReturnPast 12 months | -18.7% | +45.9% |
| 3-Year ReturnCumulative with dividends | +91.4% | +137.6% |
| 5-Year ReturnCumulative with dividends | +86.8% | +69.6% |
| 10-Year ReturnCumulative with dividends | +100.4% | +160.8% |
| CAGR (3Y)Annualised 3-year return | +24.2% | +33.4% |
Risk & Volatility
NMR is the less volatile stock with a 1.19 beta — it tends to amplify market swings less than PWP's 1.62 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NMR currently trades 93.9% from its 52-week high vs PWP's 71.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | PWPPerella Weinberg … | NMRNomura Holdings, … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.62x | 1.19x |
| 52-Week HighHighest price in past year | $25.93 | $9.58 |
| 52-Week LowLowest price in past year | $14.12 | $4.86 |
| % of 52W HighCurrent price vs 52-week peak | +71.4% | +93.9% |
| RSI (14)Momentum oscillator 0–100 | 38.9 | 53.1 |
| Avg Volume (50D)Average daily shares traded | 875K | 1.1M |
Analyst Outlook
Wall Street rates PWP as "Buy" and NMR as "Hold". Consensus price targets imply 14.8% upside for PWP (target: $21) vs -35.7% for NMR (target: $6). For income investors, NMR offers the higher dividend yield at 2.61% vs PWP's 2.06%.
| Metric | PWPPerella Weinberg … | NMRNomura Holdings, … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $21.25 | $5.79 |
| # AnalystsCovering analysts | 3 | 9 |
| Dividend YieldAnnual dividend ÷ price | +2.1% | +2.6% |
| Dividend StreakConsecutive years of raises | 1 | 2 |
| Dividend / ShareAnnual DPS | $0.38 | $36.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.5% | +1.4% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Nov 20 | Feb 26 | Change |
|---|---|---|---|
| Perella Weinberg Pa… (PWP) | 100 | 223.33 | +123.3% |
| Nomura Holdings, In… (NMR) | 100 | 162.34 | +62.3% |
Perella Weinberg Pa… (PWP) returned +87% over 5 years vs Nomura Holdings, In… (NMR)'s +70%. A $10,000 investment in PWP 5 years ago would be worth $18,682 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Perella Weinberg Pa… (PWP) | $519M | $878M | +69.2% |
| Nomura Holdings, In… (NMR) | $1.6T | $4.5T | +187.9% |
Nomura Holdings, Inc.'s revenue grew from $1.6T (2016) to $4.5T (2025) — a 12.5% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Perella Weinberg Pa… (PWP) | -4.7% | -7.4% | -57.2% |
| Nomura Holdings, In… (NMR) | 8.4% | 7.6% | -10.0% |
Nomura Holdings, Inc.'s net margin went from 8% (2016) to 8% (2025).
Chart 4P/E Ratio History — 8 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Nomura Holdings, In… (NMR) | 0.1 | 0.1 | +0.0% |
Nomura Holdings, Inc. has traded in a 0x–0x P/E range over 8 years; current trailing P/E is ~13x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Perella Weinberg Pa… (PWP) | -0.26 | -1.22 | -365.1% |
| Nomura Holdings, In… (NMR) | 35.52 | 111.03 | +212.6% |
Nomura Holdings, Inc.'s EPS grew from $35.52 (2016) to $111.03 (2025) — a 14% CAGR.
Chart 6Free Cash Flow — 5 Years
Perella Weinberg Partners generated $207M FCF in 2024 (-11% vs 2021). Nomura Holdings, Inc. generated $-869B FCF in 2025 (-259% vs 2021).
PWP vs NMR: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is PWP or NMR a better buy right now?
Nomura Holdings, Inc. (NMR) offers the better valuation at 12.7x trailing P/E (11.3x forward), making it the more compelling value choice. Analysts rate Perella Weinberg Partners (PWP) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PWP or NMR?
On forward P/E, Nomura Holdings, Inc. is actually cheaper at 11.3x.
03Which is the better long-term investment — PWP or NMR?
Over the past 5 years, Perella Weinberg Partners (PWP) delivered a total return of +86.8%, compared to +69.6% for Nomura Holdings, Inc. (NMR). A $10,000 investment in PWP five years ago would be worth approximately $19K today (assuming dividends reinvested). Over 10 years, the gap is even starker: NMR returned +160.8% versus PWP's +100.4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PWP or NMR?
By beta (market sensitivity over 5 years), Nomura Holdings, Inc. (NMR) is the lower-risk stock at 1.19β versus Perella Weinberg Partners's 1.62β — meaning PWP is approximately 36% more volatile than NMR relative to the S&P 500. On balance sheet safety, Perella Weinberg Partners (PWP) carries a lower debt/equity ratio of 82% versus 9% for Nomura Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — PWP or NMR?
Nomura Holdings, Inc. (NMR) is the more profitable company, earning 7.6% net margin versus -7.4% for Perella Weinberg Partners — meaning it keeps 7.6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NMR leads at 10.5% versus -8.9% for PWP. At the gross margin level — before operating expenses — PWP leads at 40.1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is PWP or NMR more undervalued right now?
On forward earnings alone, Nomura Holdings, Inc. (NMR) trades at 11.3x forward P/E versus 14.3x for Perella Weinberg Partners — 3.0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PWP: 14.8% to $21.25.
07Which pays a better dividend — PWP or NMR?
All stocks in this comparison pay dividends. Nomura Holdings, Inc. (NMR) offers the highest yield at 2.6%, versus 2.1% for Perella Weinberg Partners (PWP).
08Is PWP or NMR better for a retirement portfolio?
For long-horizon retirement investors, Nomura Holdings, Inc. (NMR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.19), 2.6% yield, +160.8% 10Y return). Perella Weinberg Partners (PWP) carries a higher beta of 1.62 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NMR: +160.8%, PWP: +100.4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between PWP and NMR?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: PWP is a small-cap quality compounder stock; NMR is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.